Skip to main content
NCBI home page
Cytotechnology logoLink to Cytotechnology
. 2000 Jul;33(1-3):71–81. doi: 10.1023/A:1008171109981

Improvement of a method to reproducibly immortalize human T cells by oncogene transfection

Shahabuddin Alam 1, Yoshinori Katakura 1, Hiroshi Yoshida 1, Eun-Ho Kim 2, Sanetaka Shirahata 3,✉
PMCID: PMC3466713  PMID: 19002813

Abstract

The method to immortalize human T cells efficiently and reproduciblyby oncogene transfection was improved. T cells were first grown selectively from peripheralblood lymphocytes population of healthy donors andatopic asthma patients, and from lymph nodelymphocytes population of lung cancer patients byactivating with mitogens (phytohemagglutinin andconcanavalin A) and recombinant human interleukin-2(rhIL-2) for five days. Plasmids expressingoncogenes, such as c-Ha-ras, c-myc,c-fos, v-myb and v-jun under the controlof human cytomegalovirus promoter, were then introducedinto these stimulated lymphocytes either separately orin various combinations by electropolation. Afterculturing these transfected lymphocytes for recoveryfor 1 day, they were fed every 3–4 days. Although all the control cells died within one month,oncogene-transfected lymphocytes continued toproliferate actively even for more than severalmonths, indicating that oncogene-transfectedlymphocytes were successfully immortalized. Flowcytometric analyses revealed that most of theimmortalized lymphocytes were T cells expressingCD3+ surface antigen. The ratios of CD4+and CD8+ subpopulations in immortalized T cellsderived from healthy donors varied, depending onthe kinds of oncogenes used. However, CD8+subpopulation in immortalized T cells derived fromcancer patients and atopic asthma patients weredominant, independent of the kinds of oncogenes. These immortalized T cells showed differentproliferative responses in the presence or absence ofexogenous human rhIL-2, depending on their origin ofdonors. Furthermore, immortalized T cells derivedfrom healthy donors showed stronger cytotoxicityagainst K562 cells, suggesting that MHC-nonrestrictedkiller T cells in T cell population were alsoimmortalized. Immortalized T cell lines, whichproliferate continuously without stimulation of amitogen or antigen in medium containing a lowconcentration of rhIL-2, have been maintained for morethan 2 years without any growth rate decrease.

Keywords: human T cells, immortalization, oncogenes

Full Text

The Full Text of this article is available as a PDF (297.0 KB).

References

  1. Alam S, Katakura Y, Shirahata S. Establishment of human T cell clones exhibiting natural killer-like activity. Cytotechnology. 1999;31:171–176. doi: 10.1023/A:1008072105764. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Alam S, Katakura Y, Yoshida H, Kim E-H, Shirahata S. Functional characterization of human T cells immortalized by oncogene transfection. Cytotechnology. 1997;23:185–192. doi: 10.1023/A:1007928021139. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Borek C. X-ray-induced in vitro neoplastic transformation of human diploid cells. Nature. 1980;283:776–778. doi: 10.1038/283776a0. [DOI] [PubMed] [Google Scholar]
  4. Hastie ND, Alshire RC. Human telomeres: fusion and interstitial sites. Trends Genet. 1989;5:326–331. doi: 10.1016/0168-9525(89)90137-6. [DOI] [PubMed] [Google Scholar]
  5. Hiyama K, Hirai Y, Kyoizumi S, Akiyama M, Hiyama E, Piatyzek MA, Shay JW, Ishioka S, Yamakido M. Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J Immunol. 1995;155:3711–3715. [PubMed] [Google Scholar]
  6. Jones CL, Kane MA. Oncogenic signaling. Curr Opin Oncol. 1996;8:54–59. doi: 10.1097/00001622-199601000-00010. [DOI] [PubMed] [Google Scholar]
  7. Joneson T, Bar-Saqi D. Ras effectors and their role in mitogenesis and oncogenesis. J Mol Med. 1997;75:587–593. doi: 10.1007/s001090050143. [DOI] [PubMed] [Google Scholar]
  8. Murakami H, Masui H, Sato GH, Sueoka N, Chow TP, Kano-Sueoka T. Growth of hybridoma cells in serum-free medium: ethanolamine is an essential component. Proc Natl Acad Sci USA. 1982;79:1158–1162. doi: 10.1073/pnas.79.4.1158. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Murakami H, Okazaki Y, Yamada K, Omura H. Egg yolk lipoprotein, a new supplement for the growth of mammalian cells in serum-free medium. Cytotechnology. 1988;1:159–169. doi: 10.1007/BF00146817. [DOI] [PubMed] [Google Scholar]
  10. Okano F, Tachibana H, Akiyama K, Murakami H. The detection of a breast cancer antigen on MCF-7 cells reactive with the TCR (alpha) of a specific killer T cell line. Biotherapy. 1993;6:195–203. doi: 10.1007/BF01878081. [DOI] [PubMed] [Google Scholar]
  11. Okano F, Tachibana H, Akiyama K, Shirahata S, Murakami H. Immortalization of human T lymphocytes by oncogenes. Cytotechnology. 1993;11:205–211. doi: 10.1007/BF00749871. [DOI] [PubMed] [Google Scholar]
  12. Pereira-Smith OM, Smith JR. Genetic analysis of indefinite division in human cells: Identification of four complementation groups. Proc Natl Acad Sci USA. 1988;85:6042–6046. doi: 10.1073/pnas.85.16.6042. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Rohme D. Evidence for a relationship between longevity of mammalian species and life spans of normal fibroblasts in vitro and erythrocytes in vivo. Proc Natl Acad Sci USA. 1981;78:5009–5013. doi: 10.1073/pnas.78.8.5009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Russo J, Reina D, Frederick J, Russo IH. Expression of phenotypical changes by human breast epithelial cells treated with carcinogens in vitro. Cancer Res. 1988;48:2837–2857. [PubMed] [Google Scholar]
  15. Shay JW, Wright WE. Quantitation of the frequency of immortalization of normal human diploid fibroblasts by SV40 large T-antigen. Exp Cell Res. 1989;184:109–118. doi: 10.1016/0014-4827(89)90369-8. [DOI] [PubMed] [Google Scholar]
  16. Smith JR, Pereira-Smith OM. Replicative senescence: implications for in vivo aging and tumor suppression. Science. 1996;273:63–67. doi: 10.1126/science.273.5271.63. [DOI] [PubMed] [Google Scholar]
  17. Smith KA. T cell growth factor. Immunol Rev. 1980;51:337–357. doi: 10.1111/j.1600-065x.1980.tb00327.x. [DOI] [PubMed] [Google Scholar]
  18. Stevenson M, Volsky B, Hedenskog M, Volsky DJ. Immortalization of human T lymphocytes after transfection of Epstein-Barr virus DNA. Science. 1986;233:981–983. doi: 10.1126/science.3016899. [DOI] [PubMed] [Google Scholar]
  19. Troidl B, Simmer B, Fickenscher H, Muller-Fleckenstein I, Emmrich F, Fleckenstein B, Gebhart E. Karyotypic characterization of human T cell lines immortalized by Herpes virus saimiri. Intl. J Cancer. 1994;56:433–438. doi: 10.1002/ijc.2910560325. [DOI] [PubMed] [Google Scholar]
  20. Weinberg RA. The action of oncogenes in the cytoplasm and nucleus. Science. 1985;230:770–776. doi: 10.1126/science.2997917. [DOI] [PubMed] [Google Scholar]
  21. Wright WE, Pereira-Smith OM, Shay JW. Reversible cellular senescence: Implication for immortalization of normal human diploid fibroblasts. Mol Cell Biol. 1989;9:3088–3092. doi: 10.1128/mcb.9.7.3088-3092.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Wright WE, Shay JW. The two-stage mechanism controlling cellular senescence and immortalization. Exp Gerontol. 1992;27:383–389. doi: 10.1016/0531-5565(92)90069-c. [DOI] [PubMed] [Google Scholar]
  23. Yano T, Teruya K, Shirahata S, Watanabe J, Osada K, Tachibana H, Ohashi H, Kim E-H, Murakami H. Ras oncogene enhances the production of a recombinant protein regulated by the cytomegalovirus promoter in BHK-21 cells. Cytotechnology. 1994;16:167–178. doi: 10.1007/BF00749904. [DOI] [PubMed] [Google Scholar]

Articles from Cytotechnology are provided here courtesy of Springer Science+Business Media B.V.

RESOURCES